Armytage Strategic Opportunities WS is an Managed Funds investment product that is benchmarked against ASX Index 200 Index and sits inside the Domestic Equity - Derivative Income Index. Think of a benchmark as a standard where investment performance can be measured. Typically, market indices like the ASX200 and market-segment stock indexes are used for this purpose. The Armytage Strategic Opportunities WS has Assets Under Management of 22.29 M with a management fee of 1.78%, a performance fee of 10.25% and a buy/sell spread fee of 0.25%.
The Fund distributed 1.3 cents per unit for the second half of FY2023, bringing the total FY2023 distribution to 3.3 cents per unit.
The Materials sector performed the best in June in anticipation of further stimulus from the Chinese government, particularly fiscal stimulus, after a few recent small symbolic short and medium term lending rate cuts. A virtually no inflation environment (0.2% YoY CPI) provides extra headspace for more profound stimulus. FMG, BHP and RIO advanced as iron ore surged 10%. We retained our market weight positions amongst those 3 iron ore stocks. Pure play lithium producer Pilbara (PLS) rallied 11% as the Australian government announced further investments in critical minerals, in a decarbonisation effort.
Financial stocks also performed well with the major banks recouped underperformances from previous months. At 10-11x PE (ex. CBA) and approx. 6% yield on average, the banks became attractive for value and yield hunters. Shares in Insurance Group (IAG) also traded higher after a positive update at its investor day, where the insurance company slightly lifted its forecast medium term ROE target. Tech stocks also followed the NASDAQ higher with market favoured the likes of Xero (XRO) and WiseTech (WTC). Previous month’s winners NextDC (NXT) and Altium (ALU) pared gains, which might be due to profit-taking.
Healthcare was the worst performing sector of the month with the heavy-weight CSL to blame. Shares in CSL crashed 9.47% as market caught off-guard with a new FY24 NPATA guidance, an approx. 15% downgrade to consensus as well as accelerating FX pressure, which has risen to $230m – $250m (June) vs $175m (Feb). Some positive news flows into Ramsay Health (RHC) as the private hospital operator’s Sime Darby assets were up for sale.
Other outstanding performers of the month include HomeCo (HMC), +15%, which own its first institutional mandate in form of a $350m equity commitment from an Aussie superfund for its Last Mile Logistics fund. Praemium (PPS) rallied 10% as the group’s bid to the regulator to reduce NTA requirement was approved, which was expected to provide PPS more efficiency and flexibility to pursue growth opportunities.
Product Snapshot
Performance Review
Product Overview
Peer Comparison
Product Details